2024 CASH Archives - MediaMedic

Major Announcement! Top 10 Research Advances in Chinese Hematology in 2023 Revealed

By Yin, Jiale 2024.01.26

On January 7th, the Fourth Chinese Hematology Development Conference unveiled the "Top 10 Research Advances in Chinese Hematology in 2023." The selection of the "Top 10 Research Advances in Chinese…

2024 CASH | Professor ZhiJian Xiao : Breaking Through Tradition, Marching Towards the Future, The Perfect Integration of Precision Diagnosis and Digital Science

By Yin, Jiale 2024.01.26

The diagnosis of hematologic diseases has transitioned from traditional morphology-based methods to molecular diagnostics. Simultaneously, the treatment of these diseases has also moved from traditional chemotherapy to precision therapy, particularly…

2024 CASH | Professor XiaoFan Zhu : Immunotherapy Strategy Brings Greater Benefits to Children with ALL

By Yin, Jiale 2024.01.26

Children with Acute Lymphoblastic Leukemia (ALL) have a five-year overall survival (OS) rate exceeding 90%, but about 20% still experience disease relapse. Treating these relapsed or refractory ALL cases is…

2024 CASH丨Professor RongFu : Progress in the Study of Hematological Toxicity Related to CAR-T Therapy

By Yin, Jiale 2024.01.26

Immunotherapy has recently emerged as a focal area in the research of hematologic oncology. The advancement of genetic engineering and molecular biology, coupled with deeper insights into the mechanisms of…

2024 CASH | Professor LuGui Qiu : Continuous Advances in New Drugs, The Road to Cure Multiple Myeloma is Being Realized

By Yin, Jiale 2024.01.26

From January 5th to 7th, 2024, the Fourth China Hematology Development Conference (CASH) was grandly held in Tianjin. Continuing the theme of "Big Hematology, Big Health, Big Healthcare," the conference…

2024 CASH | Professor Lei Zhang : Gene Therapy Based on AAV Vector Brings Hope for Cure to Hemophilia Patients

By Yin, Jiale 2024.01.26

From January 5th to 7th, 2024, the 4th China/Academy of Hematology Sciences Development Conference (CASH) was grandly held in Tianjin. Continuing with the theme "Comprehensive Hematology, Healthcare, and Wellness", this…

2024 CASH丨Professor Jun Shi : Gene Therapy for β-Thalassemia Using Lentiviral Vectors

By Yin, Jiale 2024.01.26

β-thalassemia is a hereditary blood disorder caused by mutations in the β-globin gene, leading to impaired synthesis or structural changes in β-globin. Gene therapy for β-thalassemia using lentiviral vectors refers…

2024 CASH | Professor Jun Ma : From ASH to CASH, the Mission of Serving Patients and Strengthening Innovation Remains Unchanged

By Yin, Jiale 2024.01.26

Organized by the China Medical Science Academy Peking Union Medical College and co-hosted by the Hematology Hospital of the China Medical Science Academy (Institute of Hematology), the 4th Chinese Hematology…

2024 CASH | ProfessorJianXiang Wang : Innovating Research and Standardizing Quality Control to Promote the Healthy Development of Hematology in China

By Yin, Jiale 2024.01.26

Editor's Note Welcoming a new chapter in hematology, the Fourth China Hematology Development Conference (CASH), organized by the Peking Union Medical College of the Chinese Academy of Medical Sciences and…

2024 CASH | Professor Hui Wei : Nurturing Growth in AML Treatment with Spring Breeze, Looking Forward to the Future of Immunotherapy

By Yin, Jiale 2024.01.26

Acute Myeloid Leukemia (AML), a group of malignancies originating from hematopoietic stem cells, stands as the most prevalent hematologic malignancy and has always been a focal point in both basic…